PYXS logo

Pyxis Oncology (PYXS) EBITDA

Annual EBITDA

-$80.27 M
+$42.50 M+34.62%

December 31, 2023


Summary


Performance

PYXS EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherPYXSprofitabilitymetrics:

Quarterly EBITDA

-$23.02 M
-$3.58 M-18.39%

September 30, 2024


Summary


Performance

PYXS Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherPYXSprofitabilitymetrics:

TTM EBITDA

-$64.04 M
+$1.81 M+2.75%

September 30, 2024


Summary


Performance

PYXS TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherPYXSprofitabilitymetrics:

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

PYXS EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+34.6%+7.3%+36.6%
3 y3 years-546.0%-30.8%+38.6%
5 y5 years-2688.1%-30.8%+38.6%

PYXS EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-16.2%+34.6%-412.9%+39.1%-0.1%+47.8%
5 y5-year-2688.1%+34.6%-687.6%+39.1%-2090.8%+47.8%
alltimeall time-2688.1%+34.6%-687.6%+39.1%-2090.8%+47.8%

Pyxis Oncology EBITDA History

DateAnnualQuarterlyTTM
Sep 2024
-
-$23.02 M(+18.4%)
-$64.04 M(-2.7%)
Jun 2024
-
-$19.45 M(+333.2%)
-$65.84 M(+2.9%)
Mar 2024
-
-$4.49 M(-73.7%)
-$63.99 M(-20.3%)
Dec 2023
-$80.27 M(-34.6%)
-$17.08 M(-31.2%)
-$80.27 M(-20.5%)
Sep 2023
-
-$24.83 M(+41.1%)
-$100.97 M(-3.2%)
Jun 2023
-
-$17.60 M(-15.3%)
-$104.33 M(-7.1%)
Mar 2023
-
-$20.76 M(-45.0%)
-$112.31 M(-8.5%)
Dec 2022
-$122.77 M
-$37.78 M(+34.0%)
-$122.77 M(+21.2%)
Sep 2022
-
-$28.19 M(+10.3%)
-$101.26 M(+19.8%)
DateAnnualQuarterlyTTM
Jun 2022
-
-$25.57 M(-18.1%)
-$84.53 M(+30.7%)
Mar 2022
-
-$31.23 M(+92.0%)
-$64.69 M(-6.3%)
Dec 2021
-$69.07 M(+455.9%)
-$16.27 M(+41.9%)
-$69.07 M(+20.7%)
Sep 2021
-
-$11.46 M(+100.2%)
-$57.21 M(+17.5%)
Jun 2021
-
-$5.72 M(-83.9%)
-$48.67 M(+13.3%)
Mar 2021
-
-$35.62 M(+707.8%)
-$42.95 M(+485.8%)
Dec 2020
-$12.43 M(+331.6%)
-$4.41 M(+50.8%)
-$7.33 M(+150.8%)
Sep 2020
-
-$2.92 M
-$2.92 M
Dec 2019
-$2.88 M
-
-

FAQ

  • What is Pyxis Oncology annual EBITDA?
  • What is the all time high annual EBITDA for Pyxis Oncology?
  • What is Pyxis Oncology annual EBITDA year-on-year change?
  • What is Pyxis Oncology quarterly EBITDA?
  • What is the all time high quarterly EBITDA for Pyxis Oncology?
  • What is Pyxis Oncology quarterly EBITDA year-on-year change?
  • What is Pyxis Oncology TTM EBITDA?
  • What is the all time high TTM EBITDA for Pyxis Oncology?
  • What is Pyxis Oncology TTM EBITDA year-on-year change?

What is Pyxis Oncology annual EBITDA?

The current annual EBITDA of PYXS is -$80.27 M

What is the all time high annual EBITDA for Pyxis Oncology?

Pyxis Oncology all-time high annual EBITDA is -$2.88 M

What is Pyxis Oncology annual EBITDA year-on-year change?

Over the past year, PYXS annual EBITDA has changed by +$42.50 M (+34.62%)

What is Pyxis Oncology quarterly EBITDA?

The current quarterly EBITDA of PYXS is -$23.02 M

What is the all time high quarterly EBITDA for Pyxis Oncology?

Pyxis Oncology all-time high quarterly EBITDA is -$2.92 M

What is Pyxis Oncology quarterly EBITDA year-on-year change?

Over the past year, PYXS quarterly EBITDA has changed by +$1.81 M (+7.28%)

What is Pyxis Oncology TTM EBITDA?

The current TTM EBITDA of PYXS is -$64.04 M

What is the all time high TTM EBITDA for Pyxis Oncology?

Pyxis Oncology all-time high TTM EBITDA is -$2.92 M

What is Pyxis Oncology TTM EBITDA year-on-year change?

Over the past year, PYXS TTM EBITDA has changed by +$36.94 M (+36.58%)